Results 261 to 270 of about 231,349 (305)

DJ-1 inhibition reshapes tumor microenvironment and potentiates immune checkpoint inhibitors. [PDF]

Sci Adv
Zhu H, Lin Y, Jiang L, Zhao W, Chen M, Lu B, Zhou Z, He Q, Yang B, Tomek P, Zhao W, Cao J.   +11 more
europepmc   +1 more source

Gut Microbiota Biomarkers in Patients with Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors. [PDF]

Life (Basel)
Cerreto M, Maestri M, Pallozzi M, Cerrito L, Stella L, Ianiro G, Gasbarrini A, Ponziani FR.   +7 more
europepmc   +1 more source

Dysautonomia and dysosmia associated with anti-Hu antibodies induced by immune checkpoint inhibitors: a case report. [PDF]

BMC Neurol
Fujimoto M, Igari K, Fujimaki M, Saiki S.   +3 more
europepmc   +1 more source

The Double-Edged Sword: How Radiotherapy Shapes the Tumor Immune Microenvironment to Modulate Responses to Checkpoint Inhibitors. [PDF]

Int J Mol Sci
Chiang CH, Chan HW, Chuang HY.
europepmc   +1 more source

Real-World Survival Over 25 Years in Extensive-Stage Small-Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors. [PDF]

Thorac Cancer
Ariyasu R, Nemoto T, Iso H, Ito M, Nibuya K, Fujishima S, Sugai M, Tsugitomi R, Amino Y, Uchibori K, Yanagitani N, Nishio M.   +11 more
europepmc   +1 more source

Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors. [PDF]

Clin Cancer Res
Ge H, Li H, Kulkarni A, Chen Z, Upadhyay P, Ferris RL, Wang JH.   +6 more
europepmc   +1 more source

Enhancing Immunotherapy in Lung Cancer: The Promise of dMMR/MSI-H Tumors and Immune Checkpoint Inhibitors. [PDF]

Health Sci Rep
Mohiuddin M.
europepmc   +1 more source

Immune Checkpoint Inhibitors in Prostate Cancer

Cancers, 2021
Metastatic prostate cancer is a lethal disease with limited treatment options. Immune checkpoint inhibitors have dramatically changed the treatment landscape of multiple cancer types but have met with limited success in prostate cancer.
Umang Swami, Agarwal Neeraj
exaly   +2 more sources